172 related articles for article (PubMed ID: 7746054)
1. Genetic diagnosis of lymph-node metastasis in colorectal cancer.
Hayashi N; Ito I; Yanagisawa A; Kato Y; Nakamori S; Imaoka S; Watanabe H; Ogawa M; Nakamura Y
Lancet; 1995 May; 345(8960):1257-9. PubMed ID: 7746054
[TBL] [Abstract][Full Text] [Related]
2. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras.
Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Hatakeyama K
Histopathology; 1998 Mar; 32(3):199-208. PubMed ID: 9568504
[TBL] [Abstract][Full Text] [Related]
3. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method.
Hayashi N; Arakawa H; Nagase H; Yanagisawa A; Kato Y; Ohta H; Takano S; Ogawa M; Nakamura Y
Cancer Res; 1994 Jul; 54(14):3853-6. PubMed ID: 8033106
[TBL] [Abstract][Full Text] [Related]
4. Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer.
Kappel S; Kandioler D; Steininger R; Längle F; Wrba F; Ploder M; Berlakovich G; Soliman T; Hetz H; Rockenschaub S; Roth E; Mühlbacher F
Transplantation; 2006 Jan; 81(1):64-70. PubMed ID: 16421478
[TBL] [Abstract][Full Text] [Related]
5. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations.
Yun K; Merrie AE; Gunn J; Phillips LV; McCall JL
J Pathol; 2000 May; 191(1):21-6. PubMed ID: 10767714
[TBL] [Abstract][Full Text] [Related]
6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
7. Genetic detection of colorectal cancer cells in circulation and lymph nodes.
Nakamori S; Kameyama M; Furukawa H; Takeda O; Sugai S; Imaoka S; Nakamura Y
Dis Colon Rectum; 1997 Oct; 40(10 Suppl):S29-36. PubMed ID: 9378009
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
9. Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
Taback B; Bilchik AJ; Saha S; Nakayama T; Wiese DA; Turner RR; Kuo CT; Hoon DS
Int J Cancer; 2004 Sep; 111(3):409-14. PubMed ID: 15221969
[TBL] [Abstract][Full Text] [Related]
10. Tumour-derived mutated K-ras codon 12 expression in regional lymph nodes of stage II colorectal cancer patients is not associated with increased risk of cancer-related death.
Clarke GA; Ryan E; Crowe JP; O'Keane JC; MacMathúna P
Int J Colorectal Dis; 2001 Apr; 16(2):108-11. PubMed ID: 11355316
[TBL] [Abstract][Full Text] [Related]
11. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer.
Yasuda K; Adachi Y; Shiraishi N; Yamaguchi K; Hirabayashi Y; Kitano S
Ann Surg Oncol; 2001 May; 8(4):300-4. PubMed ID: 11352302
[TBL] [Abstract][Full Text] [Related]
12. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
[TBL] [Abstract][Full Text] [Related]
13. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer.
Belly RT; Rosenblatt JD; Steinmann M; Toner J; Sun J; Shehadi J; Peacock JL; Raubertas RF; Jani N; Ryan CK
Clin Colorectal Cancer; 2001 Aug; 1(2):110-6. PubMed ID: 12445369
[TBL] [Abstract][Full Text] [Related]
17. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma.
Yamazaki Y; Chiba I; Hirai A; Satoh C; Sakakibara N; Notani K; Iizuka T; Totsuka Y
Head Neck; 2005 Aug; 27(8):676-81. PubMed ID: 15957194
[TBL] [Abstract][Full Text] [Related]
19. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study.
Nakanishi Y; Ochiai A; Yamauchi Y; Moriya Y; Yoshimura K; Hirohashi S
Oncology; 1999 Nov; 57(4):276-80. PubMed ID: 10575311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
